SSIINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SS Innovations International, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.45−0.08 (-3.16%)

Close on Oct 19, 2026

Market cap: $513.09M
P/E (TTM): –
Dividend yield: –

SS Innovations International, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	42	21	5.88	1.44	–	–	–	–	–	–
Cost of Revenue	23	12	5.15	1.38	–	–	–	–	–	–
Gross Profit	20	8.45	0.73	0.06	–	–	–	–	–	–
Research & Development	3.69	2.49	1.06	0.99	0.00	0.00	0.06	0.03	0.07	0.13
Selling, General & Admin	15	10	10	1.94	–	–	–	–	–	–
General & Administrative	–	–	–	1.24	0.46	0.29	0.75	0.40	0.94	0.33
Operating Expenses	28	27	21	3.02	1.41	1.10	3.37	0.96	1.01	0.46
Operating Income	-8.19	-19	-20	-2.96	–	–	–	–	–	–
Interest Expense	1.11	0.97	0.89	0.27	–	0.00	0.02	–	0.03	0.02
Interest & Investment Income	0.01	0.42	0.29	–	–	–	–	–	–	–
Income from Equity Investments	–	–	–	–	-0.08	–	–	–	–	–
Other Non-Operating Income	0.03	-0.18	-0.60	-0.26	-0.08	-0.02	-0.02	0.00	-0.03	-0.02
Asset Impairment Charges	–	–	–	–	–	–	0.04	–	–	–
Gain (Loss) on Investments	–	–	–	–	-0.08	-0.03	–	–	–	–
Pretax Income	-8.16	-19	-21	-3.21	-1.48	-1.12	-3.39	-0.96	-1.04	-0.48
Income Tax Expense	3.97	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	-21	-3.16	–	–	-3.39	-0.96	–	–
Net Income	-12	-19	-21	-3.21	-1.48	-1.12	-3.39	-0.96	-1.04	-0.48
Net Income to Common	–	–	-21	-5.60	–	–	–	–	–	–
EPS (Basic)(per share)	-0.06	-0.11	-0.14	-0.03	-0.02	-0.02	-0.05	-0.02	-0.02	-0.0092
EPS (Diluted)(per share)	-0.06	-0.11	-0.14	-0.03	-0.02	-0.02	-0.05	-0.02	-0.02	-0.0092
Shares Outstanding (Basic, Weighted)(shares)	190	171	145	128	93	76	70	68	63	60
Shares Outstanding (Diluted, Weighted)(shares)	199	181	152	128	93	76	70	68	63	60
EBITDA	-7.12	-19	-20	-2.86	–	–	–	–	–	–
Net Interest Income	0.50	0.34	0.15	0.00	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 47.6%
Operating margin: -16.2%
Net margin: -23.7%
Return on equity, FY2025: -46.9%

Financial strength

Current ratio: 2.24
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 42.8%

Valuation

P/E ratio: –
Price to sales: 9.79
Price to book: 9.61
Dividend yield: –